← Leaderboards
Charles A Giardina
University Of Connecticut Storrs
$1,815,492
Attributed
$1,815,492
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $232.2K · FY2006–17$250K$187.5K$125K$62.5K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$1,815,492 · 5
By mechanism
R21$1,426,250 · 4
R29$389,242 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cancer Prevention”
- David Heimbrook · Leidos Biomedical Research, Inc.$420,583,638
- Larry Arthur$262,753,401
- Norman Wolmark · Nsabp Foundation, Inc.$207,559,301
- Charles A Coltman · Southwest Oncology Group$197,310,355
- Philip J Disaia · University Of California Irvine$169,589,114
- Gregory H Reaman · National Childhood Cancer Foundation$156,311,017
Research focus
Cancer PreventionApoptosisMutationTissuesChemopreventionAffectCellsEventTp53 GeneColon CarcinomaLesionGenesGrowthDetectionCytokine ReceptorsGeneticGenetic PolymorphismColon NeoplasmsCd95 MoleculeFree Radical OxygenCancer CellCancer RiskButyratesCarcinogenesis Inhibitor
Grant awards (12)
(1) Intestinal Organoid Models for APC LOH$192,406
R21 · FY2017 · CA · contact PI
(1) Intestinal Organoid Models for APC LOH$232,195
R21 · FY2016 · CA · contact PI
Development of ESC-derived Intestinal Cells for Colon Cancer Research$159,426
R21 · FY2013 · CA · contact PI
Development of ESC-derived Intestinal Cells for Colon Cancer Research$183,875
R21 · FY2012 · CA · contact PI
Targeting p53 for colon cancer treatment & prevention$170,325
R21 · FY2009 · CA · contact PI
Targeting p53 for colon cancer treatment & prevention$216,892
R21 · FY2008 · CA · contact PI
Mustard Gas Exposure and Carcinogenesis of the Lung$133,571
R21 · FY2007 · ES · contact PI
Mustard Gas Exposure and Carcinogenesis of the Lung$137,560
R21 · FY2006 · ES · contact PI
COLON CANCER CHEMOPREVENTIVE AGENTS AND APOPTOSIS$97,269
R29 · FY2003 · CA
COLON CANCER CHEMOPREVENTIVE AGENTS AND APOPTOSIS$97,072
R29 · FY2002 · CA
COLON CANCER CHEMOPREVENTIVE AGENTS AND APOPTOSIS$98,000
R29 · FY2001 · CA
COLON CANCER CHEMOPREVENTIVE AGENTS AND APOPTOSIS$96,901
R29 · FY2000 · CA